15-81002329-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022566.3(TLNRD1):āc.58A>Gā(p.Ser20Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000247 in 1,417,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022566.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLNRD1 | NM_022566.3 | c.58A>G | p.Ser20Gly | missense_variant | 1/1 | ENST00000267984.4 | |
LOC128071545 | NM_001414893.1 | downstream_gene_variant | ENST00000676205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLNRD1 | ENST00000267984.4 | c.58A>G | p.Ser20Gly | missense_variant | 1/1 | NM_022566.3 | P1 | ||
ENST00000676205.1 | downstream_gene_variant | NM_001414893.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152106Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000509 AC: 4AN: 78606Hom.: 0 AF XY: 0.0000647 AC XY: 3AN XY: 46346
GnomAD4 exome AF: 0.0000213 AC: 27AN: 1265536Hom.: 0 Cov.: 30 AF XY: 0.0000226 AC XY: 14AN XY: 620022
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.58A>G (p.S20G) alteration is located in exon 1 (coding exon 1) of the MESDC1 gene. This alteration results from a A to G substitution at nucleotide position 58, causing the serine (S) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at